Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 4, 2011, Pages 817-825

  Riaz, Samreen ^a,b   Skinner, Vernon ^b   Srai, Surjit Kaila ^b  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Diabetes mellitus type 2; High dose thiamine; Protein biomarkers

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; ALPHA2 GLYCOPROTEIN; BIOLOGICAL MARKER; HAPTOGLOBIN; PREALBUMIN; RETINOL BINDING PROTEIN 4; THIAMINE; ULINASTATIN; UNCLASSIFIED DRUG; UVOMORULIN; ZINC ALPHA2 GLYCOPROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PAKISTAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEOMICS; URINALYSIS;

ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PAKISTAN; PATIENT DROPOUTS; PROTEINS; PROTEINURIA; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; THIAMINE;

EID: 78650228590     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.11.008     Document Type: Article

References (28)

1. Riaz S. Diabetes mellitus. Sci. Res. Essays 2009, 4:367-373.
2. Graves P.R., Haystead T.A.J. Molecular biologist's guide to proteomics. Microbiol. Mol. Biol. Rev. 2002, 66:39-63.
3. Young M., Byung S., Nameok I., Sung M., kyong S. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006, 29:2457-2461.
4. Anderson N., Anderson N., Toiiaksen S. Proteins of human urine concentration and analysis by two-dimensional electrophoresis. Clin. Chem. 1979, 25:1199-1210.
5. Dihazi H., Mu G., Lindner S., Meyer M., Asid A., Oellerich M., Strutz F. Characterization of diabetic nephropathy by urinary proteomic analysis. Clin. Chem. 2007, 53:1636-1645.
6. Jiang H., Guan G., Zhang R., Liu G., Cheng J., Hou X., Cui Y. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab. Res. Rev. 2009, 25:232-241.
7. Shinton N., Richradson K. Diagnostic value of serum haptoglobin. J. Clin. Pathol. 1965, 18:114-116.
8. Stejskal D., Karpíšek M., Reutová H., Stejskal P., Kotolová H., Kollár P. Serum zinc-alpha2-glycoprotein correlates with adiposity and triglycerides. Clin. Biochem. 2008, 5:313-316.
9. Fernández J., Cobián F., Méndez E. Measurement of protein HC (alpha 1 microglobulin) and protein HC-IgA complex in different body fluids. J. Clin. Pathol. 1988, 41:1176-1179.
10. Ando Y., Rinsho B. Transthyretin: its miracle function and pathogenesis. PNAS 2009, 57:228-235.
11. Riaz S., Alam S.S., Akhtar M.W. Proteomic identification of human serum biomarkers in diabetes mellitus type 2. J. Pharm. Biomed. Anal. 2010, 51:1103-1107.
12. Rabbani N., Alam S.S., Riaz S., Larkin J., Akhtar M.W., Shafi T., Thornalley P. High dose thiamine therapy for people with type 2 diabetes and microalbuminuria: a randomised double-blind, placebo-controlled study. Diabetologia 2009, 52:208-212.
13. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
14. Malard V., Gaillard J.C., Bérenguer F., Sage N., Quéméneur E. Urine proteomic profiling of uranium nephrotoxicity. Biochim. Biophys. Acta 2009, 1794:882-891.
15. Betgovargez E., Simonian M.H. Reproducibility and Dynamic Range "Characteristics of the ProteomeLab PF 2D System" Beckman Coulter Application, Information Bulletin A-1964A 2003, Beckman Coulter, Fullerton, CA.
16. Barratt J., Urine proteomics P. The present and future of measuring urinary protein components in disease. CMAJ 2007, 177:361-368.
17. Rao M., Lu X., Standely M., Pattee P., Girishie G., Dakshinamurthy K., Roberts C., Nagalla S. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 2007, 30. 629-235.
18. Chong B.E., Lubman D.M., Rosenspire A., Miller F. Rapid Commun. Mass Spectrom. 1998, 12:1986-1993.
19. Thongboonkerd V. Urinary proteomics. Towards biomarker discovery, diagnosis and prognostics. Mol. Biosyst. 2008, 4:810-815.
20. Fabre J., Balant L., Dayer P., Fox H., Vernet A. The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int. 1982, 21:730-738.
21. Butt A., Riaz S. Study of protein profiling of human urine in diabetic hypertensive nephropathy versus normal healthy controls. Diabetes Technol. Ther. 2010, 12:279-386.
22. Honga C., Chia K., Lingb S. Urinary protein excretion in type 2 diabetes with complications. J. Diabetes Complicat. 2000, 14:259-265.
23. Ruggenenti P., Fassi A., Ilieva A.P. Preventing microalbuminuria in type 2 diabetes. N. Engl. J. Med. 2004, 351:1941-1951.
24. Tepper B., Kim Y., Shete V., Shabrova E., Quadro L. Serum retinol-binding protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes. Clin. Biochem. 2010, 43:320-323.
25. Bondar O., Barnidge D., Klee E., Davis B., Klee G. LC-MS/MS quantification of zinc alpha 2 glycoprotein. Clin. Chem. 2007, 53:673-678.
26. Altland K., Benson M., Costello C., Ferlini A., Hazenberg B., Hund E., Kristen A., Linke R., Merlini G., Salvi F., Saraiva M., Singer F., Skinner M. Genetic microheterogeneity of human transthyretin detected by IEF. Electrophoresis 2007, 28:2053-2064.
27. 1-microglobulin in various hepatic disorders. Digestion 1983, 27:75-80.
28. Riaz S., Alam S.S., Srai S.K., Skinner V., Riaz A., Akhtar M.W. Proteomic identification of human urine biomarkers in diabetes mellitus type-2. Diabetes Technol. Ther. 2010, 12:12. 10.1089/dia.2010.0078.